Extracellular Matrix News Volume 13.17 | May 5 2022

    0
    17







    2022-05-05 | ECM 13.17


    Extracellular Matrix News by STEMCELL Technologies
    Vol. 13.17 – 5 May, 2022
    TOP STORY

    A Space-Time Conversion Vehicle for Programmed Multi-Drugs Delivery into Pancreatic Tumor to Overcome Matrix and Reflux Barriers

    The authors designed a mesoporous silica nanospheres-based vehicle that suggested a robust space-time conversion strategy to achieve programmed multi-drugs delivery and represented a new avenue to the treatment of pancreatic carcinoma by overcoming ECM and drug reflux barriers.
    [Advanced Science]

    Full Article

    Free E-Book: Genome Editing Applications for Disease Modeling and Cell Therapy.
    PUBLICATIONSRanked by the impact factor of the journal

    Dual Functions of MicroRNA-17 in Maintaining Cartilage Homeostasis and Protection against Osteoarthritis

    Scientists reported decreased expression of miR-17 in osteoarthritic chondrocytes and its deficiency contributed to osteoarthritis progression.
    [Nature Communications]

    Full Article

    Localized Electrical Stimulation Triggers Cell-Type-Specific Proliferation in Biofilms

    Investigators found that the stimulation of an electrode locally changed the ratio of the two major cell types comprising Bacillus subtilis biofilms, namely motile and ECM-producing cells.
    [Cell Systems]

    AbstractGraphical Abstract

    Endothelial Cell TGF-β (Transforming Growth Factor-Beta) Signaling Regulates Venous Adaptive Remodeling to Improve Arteriovenous Fistula Patency

    Inhibition of TGF-β signaling with SB431542-containing nanoparticles significantly reduced p-Smad2–positive cells in the arteriovenous fistulae (AVF) wall during the early maturation phase and was associated with decreased AVF wall thickness.
    [Arteriosclerosis Thrombosis and Vascular Biology]

    Abstract

    MBD3 Promotes Hepatocellular Carcinoma Progression and Metastasis through Negative Regulation of Tumor Suppressor TFPI2

    Methyl-CpG binding domain protein 3 (MBD3) inhibited the tissue factor pathway inhibitor 2 (TFPI2) transcription via the nucleosome remodeling and deacetylase complex-mediated deacetylation, thus reactivating the activity of matrix metalloproteinases and PI3K/AKT signaling pathway.
    [British Journal of Cancer]

    Full Article

    Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation

    Researchers revealed that acidosis could significantly trigger fatty acid synthesis to promote liver tumorigenesis by upregulating SCD1 in a PI3K/AKT activation dependent manner and simultaneously promote SCD1 binding to PPARα.
    [Molecular Cancer Research]

    Abstract

    FOXO4 Peptide Targets Myofibroblast Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice through ECM-Receptor Interaction Pathway

    Investigators explored the effect of FOXO4-D-Retro-Inverso (FOXO4-DRI) on bleomycin (BLM)-induced pulmonary fibrosis mouse model.
    [Journal of Cellular and Molecular Medicine]

    Full Article

    N6-Methyladenosine (m6A) Methyltransferase METTL3-Mediated LINC00680 Accelerates Osteoarthritis through m6A/SIRT1 Manner

    Scientists found that a m6A-related lncRNA LINC00680 upregulated in the osteoarthritis tissue and IL-1β-induced isolated primary chondrocytes.
    [Cell Death Discovery]

    Full Article

    A Human Pancreatic ECM Hydrogel Optimized for 3D Modeling of the Islet Microenvironment

    The authors demonstrated the derivation of a practical and durable hydrogel from decellularized human pancreas that supported human islet survival and function.
    [Scientific Reports]

    Full Article

    A Comprehensive Atlas of Aggrecan, Versican, Neurocan and Phosphacan Expression across Time in Wildtype Retina and in Retinal Degeneration

    Researchers provide a comprehensive atlas of the expression patterns of four individual chondroitin sulphate proteoglycans in three models of inherited retinal degeneration and wildtype mice.
    [Scientific Reports]

    Full Article

    Incorporating Fingolimod through Poly(Lactic-Co-Glycolic Acid) Nanoparticles in Electrospun Polyurethane/Polycaprolactone/Gelatin Scaffold: An In Vitro Study for Nerve Tissue Engineering

    The authors incorporated fingolimod in polylactic-co-glycolic acid and then fabricated an electrospun scaffold composed of polyurethane, polycaprolactone, and gelatin polymers containing different amount of encapsulated fingolimod.
    [Polymers For Advanced Technologies]

    Abstract

    Proteomics and Phosphoproteomics Analysis of Vitreous in Idiopathic Epiretinal Membrane Patients

    Scientists indicated the potential biomarkers or therapeutic targets for idiopathic epiretinal membrane (iERM) and provided key kinases that may have been involved in iERM.
    [Proteomics Clinical Applications]

    Abstract

    Dr. Kristina McBurney and Leanna Bedell discuss how you can use social media to advance your scientific career. Watch now.
    REVIEWS

    Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity

    Investigators discuss the current clinical landscape of immune-checkpoint inhibitors activity in the CNS and CNS immunobiology and focus on the role of glial cells in the CNS immune response to brain metastasis.
    [Cancer Discovery]

    Abstract

    Tumor Microenvironment Heterogeneity an Important Mediator of Prostate Cancer Progression and Therapeutic Resistance

    The authors summarize the challenges targeting the tumor environments, and emphasize that continued exploration of tumor heterogeneity is needed in order to offer a personalized therapy for advanced prostate cancer patients.
    [npj Precision Oncology]

    Full Article

    INDUSTRY AND POLICY NEWS

    Axogen, Inc. Announces Positive Topline Results from Phase II RECON(SM) Study for Avance® Nerve Graft

    Axogen, Inc. announced topline results from its RECON Clinical Study comparing Avance Nerve Graft to conduits in digital nerve injuries.
    [Axogen, Inc.]

    Press Release

    Agastiya Biotech Receives FDA Orphan Drug Designation for AB001 for Pancreatic Cancer and Acute Myeloid Leukemia (AML)

    Agastiya Biotech and Vopec Pharmaceuticals announce that the US FDA has granted Orphan Drug Designations for Pancreatic Cancer and AML for its novel small molecule, AB001.
    [Agastiya Biotech (Cision US, Inc.)]

    Press Release

    FEATURED EVENT

    Musculoskeletal Biology and Bioengineering

    August 7 – 12, 2022
    Andover, New Hampshire, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Stromal Immune Interactions in Cancer

    Cancer Research Center of Lyon – Lyon, France

    Tenure Track Faculty Position – Cell Signaling

    New York University College of Dentistry – New York, New York, United States

    Postdoctoral Position – 3D Bioprinting

    IMPACT – Santiago, Chile

    Research Scientist – Pancreatic Adenocarcinoma Tumor Microenvironment

    Albert Einstein College of Medicine – New York, New York, United States

    Faculty Position – Tissue Engineering

    Mayo Clinic – Jacksonville, Florida, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Extracellular Matrix News Twitter